FilingReader Intelligence

Hengrui Medicine announces HK IPO price at HKD 44.05 per share

May 21, 2025 at 05:09 PM UTCBy FilingReader AI

Jiangsu Hengrui Medicine (SSE:600276) announced the final offering price for its overseas-listed foreign shares (H shares) at HKD 44.05 per share. This price excludes a 1% brokerage commission, a 0.0027% Securities and Futures Commission transaction levy, a 0.00565% Hong Kong Stock Exchange trading fee, and a 0.00015% Financial Reporting Council transaction levy. Trading of the H shares on the Main Board of the Hong Kong Stock Exchange is expected to commence on May 23, 2025. The offering targets qualified overseas investors and eligible domestic institutions managing overseas securities investments. The company emphasized that this announcement is solely for the information of A-share investors and does not constitute an offer or solicitation to any individual or entity.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600276Shanghai Stock Exchange
Shanghai Blue Chip

News Alerts

Get instant email alerts when Jiangsu Hengrui Medicine publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →